BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 24218516)

  • 1. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
    Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
    Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient's Cohort With Esophageal Cancer.
    Konczalla L; Ghadban T; Effenberger KE; Wöstemeier A; Riethdorf S; Uzunoglu FG; Izbicki JR; Pantel K; Bockhorn M; Reeh M
    Ann Surg; 2021 Feb; 273(2):299-305. PubMed ID: 31188197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated tumor cells in bone marrow and the natural course of resected esophageal cancer.
    Vashist YK; Effenberger KE; Vettorazzi E; Riethdorf S; Yekebas EF; Izbicki JR; Pantel K
    Ann Surg; 2012 Jun; 255(6):1105-12. PubMed ID: 22580852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
    Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
    Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
    Köllermann J; Weikert S; Schostak M; Kempkensteffen C; Kleinschmidt K; Rau T; Pantel K
    J Clin Oncol; 2008 Oct; 26(30):4928-33. PubMed ID: 18794550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
    Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O
    Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
    Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
    Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
    Fehm T; Banys M; Rack B; Jäger B; Hartkopf A; Taran FA; Janni W
    Int J Cancer; 2014 Feb; 134(4):925-31. PubMed ID: 23921989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different prognostic value of circulating and disseminated tumor cells in primary breast cancer: Influence of bisphosphonate intake?
    Kasimir-Bauer S; Reiter K; Aktas B; Bittner AK; Weber S; Keller T; Kimmig R; Hoffmann O
    Sci Rep; 2016 May; 6():26355. PubMed ID: 27212060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
    Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
    Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating and disseminated tumor cells in ovarian cancer: a systematic review.
    Romero-Laorden N; Olmos D; Fehm T; Garcia-Donas J; Diaz-Padilla I
    Gynecol Oncol; 2014 Jun; 133(3):632-9. PubMed ID: 24657303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ.
    Banys M; Hahn M; Gruber I; Krawczyk N; Wallwiener M; Hartkopf A; Taran FA; Röhm C; Kurth R; Becker S; Solomayer EF; Wallwiener D; Staebler A; Fehm T
    Breast Cancer Res Treat; 2014 Apr; 144(3):531-8. PubMed ID: 24590774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer.
    Wu P; Tang RN; Zou JH; Wang FC
    Hepatogastroenterology; 2012 Oct; 59(119):2164-7. PubMed ID: 23178553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.
    Fehm T; Hoffmann O; Aktas B; Becker S; Solomayer EF; Wallwiener D; Kimmig R; Kasimir-Bauer S
    Breast Cancer Res; 2009; 11(4):R59. PubMed ID: 19664291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival.
    Seeberg LT; Waage A; Brunborg C; Hugenschmidt H; Renolen A; Stav I; Bjørnbeth BA; Brudvik KW; Borgen EF; Naume B; Wiedswang G
    Ann Surg; 2015 Jan; 261(1):164-71. PubMed ID: 24509211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients.
    Hartkopf AD; Wallwiener M; Hahn M; Fehm TN; Brucker SY; Taran FA
    Cancer Res Treat; 2016 Jan; 48(1):115-24. PubMed ID: 25687853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
    Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
    Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
    Mathiesen RR; Borgen E; Renolen A; Løkkevik E; Nesland JM; Anker G; Ostenstad B; Lundgren S; Risberg T; Mjaaland I; Kvalheim G; Lønning PE; Naume B
    Breast Cancer Res; 2012 Aug; 14(4):R117. PubMed ID: 22889108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.